Conditions: Alcoholism
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 141
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the effects of SCH 900435 (Org 25935, MK-8435) on heavy drinking, safety and tolerability of SCH 900435 in participants with alcohol dependence.

Detailed description:

Arms:
arm 1: Participants received SCH 900435 12 mg (as three SCH 900435 4 mg tablets) by mouth twice daily for 12 weeks. arm 2: Participants received matching placebo tablets by mouth twice daily for 12 weeks.

Interventions: intervention 1: SCH 900435 intervention 2: Placebo
Intervention descriptions: intervention 1: tablets intervention 2: tablets

Protocol document: